Shareholders of Aspect Medical Systems filed a lawsuit to block the Mansfield, Mass.-based medical devices giant's $210 million acquisition of the brain monitoring firm.
The deal would see the Mansfield, Mass.-based medical devices giant pay $12 per share for Aspect, a Norwood, Mass.-based maker of brain monitoring equipment that measures the effects of anesthesia and sedation.
The lawsuit accuses Aspect's management of breaching its fiduciary duty by agreeing to the merger, alleging that the takeover price is unfair in seeking to take advantage of the global recession to snap up the company at a price that's far below the actual value of the company.
But if the deal is consummated, Covidien will pay a roughly 56 percent premium over Aspect Medical's $7.67 share price as of market close Sept. 25. Aspect shares have plunged since a reaching $37 per share in 2006; news of the deal Sept. 28 sent that number to $11.90, just under its 52-week high.
The company posted net income of $11.1 million on sales of $99.3 million last year. During the second quarter, Aspect reported sales of $24.9 million, down slightly from $25.2 million during the same period last year. And although net income plummeted from $119 million during the 2008 second quarter to $307,000 during the three months ended July 4, operating margins improved to 2.5 percent, compared with -3.8 percent on a nearly million-dollar loss during Q2 2008.
The buyout announcement came nearly four months after Aspect Medical narrowly avoided a nasty proxy fight by offering a seat on its board of directors to a trio of dissident shareholders from First Biomed LLC.
VertiFlex says it won pre-market approval from the FDA for its Superion interspinous spacer.
China is investigating a former top healthcare official on suspicion of bribery.
Medtronic is reportedly looking to grow its presence in China with lower-cost devices, as well as...
Here's a look at some of the top mergers & acquisitions stories for medical device companies this...
A study of replacement heart valves treated with calcification-reducing coatings shows that the...